dc.contributor.author | Band, Margaret M | |
dc.contributor.author | Sumukadas, Deepa | |
dc.contributor.author | Struthers, Allan D | |
dc.contributor.author | Avenell, Alison | |
dc.contributor.author | Donnan, Peter T | |
dc.contributor.author | Kemp, Paul R | |
dc.contributor.author | Smith, Karen T | |
dc.contributor.author | Hume, Cheryl L | |
dc.contributor.author | Hapca, Adrian | |
dc.contributor.author | Witham, Miles D | |
dc.date.accessioned | 2018-01-26T13:26:07Z | |
dc.date.available | 2018-01-26T13:26:07Z | |
dc.date.issued | 2018-01-04 | |
dc.identifier | 115160567 | |
dc.identifier | 231f7a60-c432-48d1-8c36-88f8ca0a14e0 | |
dc.identifier | 29301558 | |
dc.identifier | 85042508359 | |
dc.identifier.citation | Band , M M , Sumukadas , D , Struthers , A D , Avenell , A , Donnan , P T , Kemp , P R , Smith , K T , Hume , C L , Hapca , A & Witham , M D 2018 , ' Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial) : study protocol for a randomised controlled trial ' , Trials , vol. 19 , 6 . https://doi.org/10.1186/s13063-017-2390-9 | en |
dc.identifier.issn | 1745-6215 | |
dc.identifier.other | PubMedCentral: PMC5753568 | |
dc.identifier.uri | http://hdl.handle.net/2164/9948 | |
dc.description | This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (grant number 13/53/03). The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NHS, NIHR or Department of Health. The authors acknowledge the financial assistance and support of the NIHR Ageing Clinical Research Network and acknowledge support from the Chief Scientist Office, Scottish Government Support for Science funding stream. The Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. | en |
dc.format.extent | 901053 | |
dc.language.iso | eng | |
dc.relation.ispartof | Trials | en |
dc.subject | Journal Article | en |
dc.subject | older people | en |
dc.subject | perindopril | en |
dc.subject | leucine | en |
dc.subject | sarcopenia | en |
dc.subject | physical function | en |
dc.subject | quality of life | en |
dc.subject | randomised controlled trial | en |
dc.subject | R Medicine | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | 13/53/03 | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | 13/53/03 | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject.lcc | R | en |
dc.title | Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial) : study protocol for a randomised controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/s13063-017-2390-9 | |